Achillion Pharma (ACHN) Misses Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Achillion Pharma (ACHN) Misses Q4 EPS by 3c

Data Could Lead to Achillion Pharmaceuticals (ACHN) Takeover By Year End - Analyst

March 6, 2015 1:32 PM EST

William Blair analyst Y. Katherine Xu offered some interesting commentary on Achillion Pharmaceuticals (NASDAQ: ACHN) after the company's "uneventful" fourth quarter report. While keeping her Market Perform rating and lowering her price target to $14.00 (from $15.00), Xu highlighted that Achillion intends to initiate three different combination studies in the treatment of hepatitis C virus (HCV) during 2015 to... More